Workflow
Commerce to Present at Upcoming Investor Conferences
Globenewswire· 2025-11-25 21:05
AUSTIN, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced the following upcoming investor conference presentations. Chief Executive Officer Travis Hess and Chief Financial Officer Daniel Lentz will present and host meetings with institutional investors at: ...
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 14, 2025
Globenewswire· 2025-11-25 21:05
Core Insights - The total short interest in Nasdaq securities increased to 17,958,812,154 shares as of November 14, 2025, up from 17,265,222,015 shares in the previous reporting period [3] - The average days to cover for all Nasdaq securities rose to 1.75 days compared to 1.54 days in the prior period, indicating a higher level of short selling activity [3] Nasdaq Global Market - Short interest in 3,414 Nasdaq Global Market securities reached 14,632,128,542 shares, an increase from 14,079,841,205 shares reported for the previous settlement date [1] - The average days to cover for the Global Market securities was 2.16 days, up from 1.99 days in the prior reporting period [1] Nasdaq Capital Market - In the Nasdaq Capital Market, short interest totaled 3,326,683,612 shares across 1,697 securities, compared to 3,185,380,810 shares in the previous period [2] - The average daily volume remained stable at 1.00 day for both reporting periods [2] Short Sale Definition - A short sale is defined as the sale of a security that the seller does not own or any sale completed by delivering a borrowed security [4]
URBN Reports Record Q3 Sales and Income
Globenewswire· 2025-11-25 21:05
Core Insights - Urban Outfitters, Inc. reported record net income of $116.4 million and earnings per diluted share of $1.28 for the three months ended October 31, 2025, with a total net income of $368.7 million and earnings per diluted share of $4.01 for the nine months ended October 31, 2025 [1][11]. Financial Performance - Total Company net sales for the three months ended October 31, 2025, increased by 12.3% to a record $1.53 billion, while net sales for the nine months increased by 11.5% to $4.36 billion [2][3]. - Retail segment net sales increased by 9.6% for the three months and 8.0% for the nine months, with comparable Retail segment net sales rising by 8.0% [2][3]. - Subscription segment net sales surged by 48.7% for the three months and 53.4% for the nine months, driven by a significant increase in average active subscribers [2][3]. Segment Performance - Comparable Retail segment net sales growth was driven by Urban Outfitters (12.5%), Anthropologie (7.6%), and Free People (4.1%) for the three months ended October 31, 2025 [2]. - For the nine months, comparable Retail segment net sales increased by 6.8% at Anthropologie, 6.4% at Urban Outfitters, and 4.7% at Free People [3]. Profitability Metrics - Gross profit for the three months ended October 31, 2025, increased by 13.3% to $563.3 million, with a gross profit rate improvement of 31 basis points [6][7]. - For the nine months, gross profit dollars rose by 15.7% to $1.62 billion, with a gross profit rate increase of 135 basis points [6][7]. Expenses and Taxation - Selling, general and administrative expenses increased by 13.7% for the three months and 11.5% for the nine months, primarily due to increased marketing expenses [9]. - The effective tax rate decreased to 23.6% for the three months and 22.2% for the nine months ended October 31, 2025, compared to the previous year [10]. Share Repurchase and Expansion - The company repurchased 3.3 million shares for approximately $152 million during the nine months ended October 31, 2025, with 14.7 million shares remaining under the repurchase program [12]. - Urban Outfitters opened 41 new retail locations and closed 6 during the nine months ended October 31, 2025 [13].
Talen Energy Completes Freedom and Guernsey Acquisitions
Globenewswire· 2025-11-25 21:05
Core Insights - Talen Energy Corporation has completed the acquisition of two natural gas-fired power plants, adding 2.9 gigawatts of capacity to its portfolio, enhancing its ability to provide reliable, low-carbon energy solutions [1][2] Group 1: Acquisitions - The acquired assets include the Freedom Generating Station in Pennsylvania and the Guernsey Power Station in Ohio, both recognized as best-in-class natural gas facilities within the PJM region [2] - The acquisitions are expected to be immediately accretive to Talen's financial performance and align with the company's strategic focus on maintaining balance sheet discipline [2] Group 2: Financial Strategy - Talen successfully financed the acquisitions through various transactions, including $2.7 billion in senior unsecured notes and a $1.2 billion senior secured term loan B credit facility [2] - The company also secured commitments to increase its revolving credit facility to $900 million and its letter of credit facility to $1.1 billion, further supporting its financial operations [2] Group 3: Operational Integration - Talen's team is prepared to integrate the new assets into its existing portfolio, with a focus on maintaining safe and efficient operations [3] - The company expresses confidence in the operational teams from the acquired plants to continue their track record of compliance and efficiency as part of Talen's fleet [3] Group 4: Company Overview - Talen Energy operates approximately 13.2 gigawatts of power infrastructure across the United States, including a significant fossil fuel fleet and 2.2 gigawatts of nuclear power [4] - The company is positioned to meet the growing energy demands of hyperscale data centers, which increasingly require reliable and clean power solutions [4]
Peloton Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
Globenewswire· 2025-11-25 21:05
Core Insights - Peloton Interactive, Inc. will have its CEO Peter Stern participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 3, 2025 [1] - The event will be accessible via a live webcast and replay on the Company's Investor Relations website [1] Company Overview - Peloton provides Members with high-quality equipment, wellness solutions, innovative software, expert instruction, and a supportive fitness community [2] - Founded in 2012 and headquartered in New York City, Peloton has millions of Members across the US, UK, Canada, Germany, Australia, and Austria [2]
NewLake Capital Partners to Attend MJBizCon 2025 in Las Vegas
Globenewswire· 2025-11-25 21:05
Core Insights - NewLake Capital Partners, Inc. is participating in MJBizCon 2025, a major cannabis industry conference, from December 2–5, 2025, in Las Vegas [1][2] - The conference is the largest B2B cannabis event globally, attracting over 20,000 professionals and 1,000 exhibitors, serving as a key platform for networking and identifying trends in the cannabis economy [2] Company Overview - NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides capital to state-licensed cannabis operators through sale-leaseback transactions and funding for build-to-suit projects [3] - The company owns a portfolio of 34 properties, which includes 15 cultivation facilities and 19 dispensaries [3]
Nukkleus Inc. Announces Date of the Special Meeting of Stockholders to Approve Acquisition of Star 26 Capital, Inc.
Globenewswire· 2025-11-25 21:05
Core Viewpoint - Nukkleus Inc. is set to hold a special meeting on December 16, 2025, to vote on the acquisition of Star 26 Capital, Inc. and related share issuance proposals [1][3]. Company Overview - Nukkleus Inc. focuses on acquiring and scaling mission-critical suppliers in the defense, aerospace, and advanced manufacturing sectors, targeting Tier 2 and Tier 3 companies that are essential to national security infrastructure in the U.S., Israel, and Europe [4]. - The company employs a proprietary capital model to integrate operational capabilities, financial discipline, and long-term vision, aiming to modernize and expand strategic suppliers [4]. Acquisition Details - Stockholders will vote on the acquisition of 100% of Star 26, a defense-focused acquisition company [3]. - The meeting will also address the issuance of shares related to the conversion of outstanding Series A Convertible Preferred Stock and associated warrants, as well as shares connected to a $250 million equity line of credit [3]. Portfolio and Strategy - Nukkleus combines organic growth with disciplined mergers and acquisitions (M&A) to achieve transformational scale, positioning itself at the core of 21st-century defense industrial strategy [5]. - The company's portfolio includes suppliers such as B. Rimon Agencies Ltd., which provides generators for the "iron dome" launcher system, a majority interest in Water.OI Ltd. focused on smart hydration technology, and a convertible loan to ITS Industrial Techno-logic Solutions [5].
Safe Bulkers, Inc. Reports Third Quarter 2025 Results and Declares Dividend on Common Stock
Globenewswire· 2025-11-25 21:05
Core Viewpoint - Safe Bulkers, Inc. reported its unaudited financial results for Q3 and the first nine months of 2025, highlighting a decrease in net revenues and net income compared to the same periods in 2024, while also declaring a cash dividend of $0.05 per share [1][38]. Financial Highlights - Net revenues for Q3 2025 were $73.1 million, a decrease of 4% from $75.9 million in Q3 2024 [2]. - Net income for Q3 2025 was $17.8 million, down from $25.1 million in Q3 2024 [2]. - Adjusted net income for Q3 2025 was $13.9 million, compared to $19.0 million in Q3 2024 [2]. - EBITDA for Q3 2025 was $40.1 million, down from $47.4 million in Q3 2024 [2]. - Earnings per share for Q3 2025 were $0.15, compared to $0.22 in Q3 2024 [2]. Average Daily Results - The average time charter equivalent (TCE) rate for Q3 2025 was $15,507, compared to $17,108 in Q3 2024 [3]. - Daily vessel operating expenses for Q3 2025 were $5,104, a decrease from $5,311 in Q3 2024 [3]. - Daily general and administrative expenses increased to $1,762 in Q3 2025 from $1,680 in Q3 2024 [3]. Selected Financial Highlights - Total cash as of Q3 2025 was $123.9 million, down from $135.9 million in Q4 2024 [8]. - Total debt as of Q3 2025 was $516.3 million, compared to $489.8 million in Q3 2024 [8]. - The number of vessels at the end of Q3 2025 was 45, consistent with Q3 2024 [8]. Management Commentary - The President of the Company noted the impact of geopolitical factors on market volatility and the ongoing fleet renewal strategy, including the sale of older vessels [12]. - The Company is focused on aligning its financing with sustainability goals through a new $75 million sustainability-linked credit facility [14]. Fleet Update - As of November 21, 2025, the fleet consisted of 45 vessels with an average age of 10.3 years [18]. - The Company has an orderbook of six newbuilds, including two methanol dual-fueled vessels scheduled for delivery in 2026 and 2027 [19]. Vessel Sales - The Company sold two Kamsarmax class vessels in 2025 for gross sale prices of $12.5 million and $11.5 million, respectively, as part of its fleet renewal strategy [20][21]. Chartering Strategy - The Company employs its vessels under both period time charters and spot time charters, with a focus on maintaining flexibility in low charter market conditions [22]. - As of November 21, 2025, the Company had contracted revenue of approximately $153.5 million from its charter contracts [23]. Debt and Liquidity - As of September 30, 2025, the Company had a consolidated debt of $525.0 million and a consolidated leverage of approximately 35% [26]. - The Company had $123.9 million in cash and $266.5 million in undrawn borrowing capacity as of September 30, 2025 [32]. Dividend Policy - The Board declared a cash dividend of $0.05 per share, payable on December 19, 2025 [38].
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
Globenewswire· 2025-11-25 21:00
Core Insights - Quantum BioPharma Ltd. is facing allegations of stock market manipulation, which has led to a USD $700 million lawsuit against CIBC and RBC, two of Canada's largest banks [2][3]. Company Overview - Quantum BioPharma is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and metabolic disorders, including its lead compound, Lucid-MS, which aims to prevent and reverse myelin degradation associated with multiple sclerosis [4]. - The company retains a 19.86% ownership stake in Unbuzzd Wellness Inc., which is involved in the development of a product called unbuzzd™, and has a royalty agreement that includes 7% of sales until total payments reach $250 million, after which the royalty rate drops to 3% [4]. Industry Context - The investigative series by CTV News highlights the illegal practice of "stock spoofing," which is a form of market manipulation that affects retail investors and can derail important research and development efforts in the biopharmaceutical sector [2][3].
Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
Globenewswire· 2025-11-25 20:43
Core Points - Transgene has requested a suspension of trading for its shares on Euronext Paris starting November 26, 2025, pending the announcement of its capital increase results [1] - Trading is expected to resume on November 27, 2025, at market opening [1] Company Overview - Transgene is a biotechnology company focused on developing immunotherapy products for cancer treatment, with a portfolio that includes several viral vector-based immunotherapies in clinical development [2] - The lead candidate, TG4050, is the first individualized treatment from the myvac® platform, showing clinical proof of concept in patients with head and neck cancer [2] - Other candidates in development include BT-001, an oncolytic virus based on the patented invir.IO® platform [2] Technology and Innovation - The myvac® platform integrates tumor mutations identified through artificial intelligence into a viral vector, marking a step into precision medicine [3] - The invir.IO® platform allows for the design of multifunctional oncolytic viruses, showcasing Transgene's expertise in viral vector engineering [3]